Noir Expects to See Strong Revenue Growth in 2024 Exceeding $7M, Up from $4.6M in 2023 BOCA RATON, FL / ACCESSWIRE / September 11, 2024 / CYIOS Corp (OTC PINK:CYIO), a publicly traded holding company, is pleased to announce it has successfully closed the strategic acquisition of Noir Medical Supplies, ("Noir") a company specializing in providing top-tier medical equipment and supplies. The acquisition marks a significant milestone for CYIOS with anticipated strong revenue growth in 2024 exceeding $7Million, up from $4.6Million in 2023.
| Financial Services Industry | Financials Sector | John Fredrick O'Shea CEO | OTC PINK Exchange | 23256Y108 CUSIP |
| US Country | 15 Employees | - Last Dividend | 17 May 2005 Last Split | - IPO Date |
CYIOS Corporation, a multifaceted company established in 1997, is prominently engaged in constructing a comprehensive crypto platform via its subsidiaries. With headquarters in Deerfield Beach, Florida, CYIOS has tailored its focus towards a revolutionary approach in the financial technology and health and wellness markets. The corporation steers the development, distribution, and licensing of proprietary products while also evaluating strategic acquisition opportunities to bolster its market presence and diversify its offerings.
CYIOS Corporation has developed and offers a diverse range of products and services through its subsidiaries, primarily focusing on the crypto-currency sector and health and wellness industry: